Identification of a 31 kDa protein in Saccharomyces cerevisiae whose phosphorylation is controlled negatively by the CDC25 gene product

Department of Biology, University of California, San Diego, La Jolla, CA 92093, USA ABSTRACT Summary: Phosphoprotein patterns in two mutants of Saccharomyces cerevisiae, cdc25-20 (ts) and cdc25-20 (ts) bcy 1 , were analysed by two-dimensional polyacrylamide gel electrophoresis. Comparison with the p...

Full description

Saved in:
Bibliographic Details
Published inJournal of general microbiology Vol. 134; no. 9; pp. 2481 - 2496
Main Authors Tripp, M.L, Pinon, R
Format Journal Article
LanguageEnglish
Published London Soc General Microbiol 01.09.1988
New York, NY Cambridge University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Department of Biology, University of California, San Diego, La Jolla, CA 92093, USA ABSTRACT Summary: Phosphoprotein patterns in two mutants of Saccharomyces cerevisiae, cdc25-20 (ts) and cdc25-20 (ts) bcy 1 , were analysed by two-dimensional polyacrylamide gel electrophoresis. Comparison with the phosphoprotein patterns of the mutants cyrl-2 (ts) and bcy 1 , analysed in a previous study, demonstrated not only that the CDC25 gene product is a positive element in the regulation of adenylyl cyclase activity, as suggested by recent studies, but that it is also a negative element in the phosphorylation of a 31 kDa protein (p31c and p31d), a protein whose phosphorylation is correlated with cell cycle arrest, and dephosphorylation with cell cycle initiation, respectively. Moreover, the phosphorylation phenotype of p31c and p31d suggests that the activity of the CDC25 protein is subject to feedback regulation by cAMP-dependent protein kinase, and that the CDC25 protein is a key element in an ammonium (NH + 4 ) signal-response system. Present address: Miller Brewing Company, Milwaukee, WI 53201, USA.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-1287
1350-0872
1465-2080
DOI:10.1099/00221287-134-9-2481